Cryo-Cell International, Inc.
CCEL
$3.41
-$0.11-3.13%
AMEX
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.04% | 0.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.04% | 0.23% | |||
| Cost of Revenue | -72.81% | 238.23% | |||
| Gross Profit | 244.34% | -70.95% | |||
| SG&A Expenses | -8.01% | 40.56% | |||
| Depreciation & Amortization | 0.05% | -1.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -41.42% | 99.33% | |||
| Operating Income | 119.29% | -308.72% | |||
| Income Before Tax | 101.52% | -490.56% | |||
| Income Tax Expenses | 102.85% | -286.56% | |||
| Earnings from Continuing Operations | 101.23% | -609.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 101.23% | -609.39% | |||
| EBIT | 119.29% | -308.72% | |||
| EBITDA | 127.10% | -273.64% | |||
| EPS Basic | 101.22% | -609.57% | |||
| Normalized Basic EPS | 107.01% | -421.21% | |||
| EPS Diluted | 101.22% | -626.56% | |||
| Normalized Diluted EPS | 107.01% | -421.82% | |||
| Average Basic Shares Outstanding | 0.00% | -0.03% | |||
| Average Diluted Shares Outstanding | 0.01% | -0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||